Plant Advanced Technologies SA

Plant Advanced Technologies SA

EEURONEXT:ALPAT
3.98
EUR
+0.04
(+1.02%)
9.22MMarket Cap
Mar 03Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.26
1.41
1.12
1.28
0.87
1.16
1.08
1.15
1.42
1.39
1.55
1.73
1.01
- -
Basic EPS, GAAP
-0.11
-0.93
-0.99
-1.25
-0.73
0.88
-0.5
-0.61
-0.8
-0.36
0.07
0.84
0.51
- -
Free Cash Flow per Basic Share
-1.98
-2.64
-2.69
-1.97
-1.66
- -
- -
-1.61
- -
- -
0.89
1.87
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
3.41
3.71
8.77
7.33
6.96
8.62
9.26
8.6
7.8
7.41
7.48
8.25
8.75
8.75
Tangible Book Value per Share
1.68
1.59
7.23
5.57
4.36
6.11
6.2
6.45
5.71
4.71
4.2
4.97
5.46
5.46
Basic Weighted Avg Shares
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Sales/Revenue/Turnover
1
1
1
1
1
1
1
1
2
2
2
2
1
- -
Operating Margin (%)
-131.64
-119.84
-159.28
-159.62
-231.38
-163.48
-118.92
-126.74
-105.48
-78.65
-35.62
11.88
-17.99
- -
Depreciation Expense
1
- -
1
- -
- -
1
- -
1
- -
- -
1
- -
- -
- -
Net Income, GAAP
- -
-1
-1
-1
-1
1
-1
-1
-1
- -
- -
1
1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-8.73
-65.93
-88.34
-97.52
-83.64
75.72
-46.15
-52.88
-56.46
-25.99
4.71
48.52
50.04
- -
Working Capital
1
2
6
4
2
2
3
2
2
2
1
- -
-2
-2
LT Debt
1
2
2
2
2
3
3
4
5
5
4
3
1
1
Total Equity
2
2
8
7
6
8
10
9
8
8
8
9
10
10
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-3.11
-26.73
-17.78
-15.74
-10.38
11.7
-5.89
-6.87
-9.76
-4.87
0.98
10.81
5.99
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'23
Jun'25
Dec'25
ST Debt
- -
- -
3
LT Borrowings
4
4
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
9
10
9

Working Capital

EUR

•

in mil. unless spec.
Dec'23
Jun'25
Dec'25
Total Current Assets
3
2
3
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
- -
1
Inventories
1
1
1
Total Current Liabilities
2
3
5
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
3
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.3%
1.37%
7.34%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
51.72%
179.9%
-39.11%
Sales/Revenue/Turnover
4.05%
1.07%
-40.95%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
2
2024
- -
- -
2
2025
- -
- -
1

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.07
2024
- -
- -
0.84
2025
- -
- -
0.51

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
Jean-Paul Fèvre
Full Time Employees
11
Sector
Process industries
Industry
Chemicals: specialty
Address
19 Avenue de la forEt de Haye Vandoeuvre-les-Nancy GES France 54500
IPO Date
Apr 8, 2015
Business
Plant Advanced Technologies S.A. is a plant biotechnology company specializing in the discovery, development, and eco-friendly industrial production of rare plant-based active biomolecules for the cosmetic, pharmaceutical, and agrochemical industries. Founded in 2005 and headquartered in Vandœuvre-lès-Nancy, France, the company offers core products and services including the patented "PAT Plant Milking" technology for producing active extracts via living plant root stimulation without plant destruction, and "PAT Target Binding" technology for identifying ligands that bind specific protein targets such as enzymes. The company produces high-value natural active ingredients tailored primarily for cosmetic formulations, pharmaceutical applications, and plant protection solutions. Plant Advanced Technologies operates mainly in France but serves global markets in cosmetics, pharmaceuticals, nutraceuticals, and agrochemicals, leveraging its patented biotechnologies to ensure biodiversity preservation while accessing rare plant compounds. Key product categories include natural active ingredients for skincare and cosmetic uses, pharmaceutical actives, agrochemical biomolecules, and customized bioactive solutions. Recent major company developments include the launch of new active ingredients such as HydraQueen Exudactive® for cosmetics showcased at trade events in 2024, and the establishment of a flexible €1 million equity financing line with Iris Capital to support future growth projects. The company has strengthened strategic partnerships, notably with Clariant for co-developed cosmetic products and has expanded innovation programs including a bio-herbicide discovery project under government funding initiatives. Financially, Plant Advanced Technologies achieved its first positive operating profit in 2024 and shows a strong outlook on profitability targets for 2025. The company also continuously enhances its operational infrastructure, maintaining ISO 9001 certification and recently moving to new headquarters facilities in Vandœuvre-lès-Nancy. Overall, Plant Advanced Technologies leads in plant-based biotechnological innovation by producing differentiated, traceable natural actives with sustainable processes, targeting specialty chemicals in cosmetics, pharmaceuticals, and agrochemicals worldwide from its France base. The company holds a significant portfolio of patents and trademarks to protect its unique technologies and products. This positions it as a key player in environmentally conscious biotechnology for active molecule production.